Serrano AL, Muñoz-Cánoves P. Regulation and dysregulation of fibrosis in skeletal muscle. Exp Cell Res. 2010 June 4
Guerrero L, Marco-Ferreres R, Serrano AL, Arredonde JJ, Cervera M. Secondary enhancers synergise with primary enhancers to guarantee fine-tuned muscle gene expression. Dev Biol. 2010 Jan 1;337(1):16-28.
Perdiguero E, Sousa-Victor P, Ballestar E, Muñoz-Cánoves P. Epigenetic regulation of myogenesis. Epigenetics. 4(8):541-50, 2009
Vidal B, Serrano AL, Tjwa M, Suelves M, Ardite E, De Mori R, Baeza B, Martínez de Lagrán M, Ruiz-Bonilla V, Jardí M, Gherardi R; Degen J, Christov C, Dierssen M, Dewerchin M, Carmeliet P, Muñoz-Cánoves P. Fibrinogen drives dystrophic muscle fibrosis via a TGFb/alternative macrophage activation pathway. Genes & Development, 22:1747-52, 2008
Serrano AL, Baeza-Raja B, Perdiguero E, Jardí M, Muñoz-Cánoves P. Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab. 7:33-44, 2008
Ruiz-Bonilla V, Perdiguero E, Gresh L, Serrano AL, Zamora M, Sousa-Victor P, Jardí M, Wagner EF, Muñoz-Cánoves P. Efficient adult skeletal muscle regeneration in mice deficient in p38beta, p38gamma and p38delta MAP kinases. Cell Cycle.7:2208-14, 2008
Suelves M, Vidal B, Serrano A, Tjwa M, Roma J, López-Alemany R, Luttun A, Mtnez Lagrán M, Díaz MA, Jardí M, Roig M, Dierssen M, Dewerchin M, Carmeliet P, Muñoz-Cánoves P. uPA deficiency exacerbates muscular dystrophy in mdx mice. J. Cell Biol. 178: 1039-51, 2007
Perdiguero E, Ruiz-Bonilla V, Gresh L, Hui L, Ballestar E, Sousa-Victor P, Baeza-Raja B, Jardi M, Bosch-Comas A, Esteller M, Caelles C, Serrano A, Wagner EF, Munoz-Canoves P. Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38alpha in abrogating myoblast proliferation. EMBO J. 26:1245-56, 2007
Lluís F, Perdiguero E, Nebreda AR, Muñoz-Cánoves P. Regulation of skeletal muscle gene expression by p38 MAP kinases. Trends Cell Biol. 16:36-44, 2006
Nagamine Y, Medcalf RL, Muñoz-Cánoves P. Transcriptional and posttranscriptional regulation of the plasminogen activator system. Thromb Haemost. 93:661-675, 2005
Vidal B, Parra M, Jardi M, Saito S, Appella E, Muñoz-Cánoves P. The alkylating carcinogen N-methyl-N'-nitro-N-nitrosoguanidine activates the plasminogen activator inhibitor-1 gene through sequential phosphorylation of p53 by ATM and ATR kinases. Thromb Haemost. 93: 584-91, 2005
Lluís F, Ballestar E, Suelves M, Esteller M, Sartorelli V, Muñoz-Cánoves P. E47 phosphorylation by p38 MAP kinase promotes MyoD/E47 association and muscle-specific gene transcription. EMBO J. 24: 974-984, 2005
Baeza-Raja B, Muñoz-Cánoves P. p38 MAPK-induced NF-kB activity is required for skeletal muscle differentiation. Mol. Biol. Cell. 15: 2013-2026, 2004
Suelves M., Lluis F, Ruiz V, Nebreda AR, Muñoz-Cánoves P. Phosphorylation of the transactivation domain of MRF4 by p38 MAPK mediates repression of specific myogenic genes. EMBO J. 33: 365-375, 2004
Suelves M, López-Alemany R, Lluís F, Aniorte G, Serrano E, Parra M, Carmeliet P, Muñoz-Cánoves P Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo Blood 99: 2835-2844, 2002